MMP9 and amyotrophic lateral sclerosis: In summary, we provide evidence for dysfunction of C9orf72 mutant microglia, and primary neurotoxicity of C9orf72 mutant microglia mediated by MMP9 as a therapeutic target to counteract neurodegeneration in C9orf72-ALS.